| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 70450 |
Computed tomography, head or brain; without contrast material |
7,497 |
6,608 |
$644K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,341 |
4,571 |
$607K |
| 80053 |
Comprehensive metabolic panel |
16,106 |
12,113 |
$347K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31,295 |
23,651 |
$338K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,089 |
2,775 |
$331K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,216 |
2,912 |
$311K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,202 |
32,625 |
$303K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,189 |
2,565 |
$303K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,695 |
3,881 |
$293K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,923 |
3,519 |
$257K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,926 |
4,084 |
$232K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
979 |
810 |
$206K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,500 |
3,072 |
$194K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,155 |
14,705 |
$188K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,163 |
2,406 |
$188K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,178 |
3,724 |
$187K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,569 |
1,373 |
$170K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,806 |
4,176 |
$152K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
525 |
376 |
$147K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,398 |
1,195 |
$140K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,810 |
4,420 |
$139K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,722 |
4,820 |
$121K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
534 |
396 |
$120K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,960 |
3,489 |
$113K |
| 83880 |
|
5,122 |
4,477 |
$109K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,173 |
3,671 |
$108K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,011 |
9,545 |
$99K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,146 |
3,443 |
$98K |
| 84484 |
|
12,919 |
9,367 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,566 |
2,508 |
$93K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
389 |
374 |
$88K |
| 36415 |
Collection of venous blood by venipuncture |
14,682 |
10,441 |
$82K |
| 87634 |
|
1,796 |
1,584 |
$81K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,957 |
4,971 |
$74K |
| 71045 |
Radiologic examination, chest; single view |
12,217 |
10,400 |
$71K |
| 71046 |
Radiologic examination, chest; 2 views |
5,805 |
5,107 |
$68K |
| 80050 |
General health panel |
1,416 |
1,288 |
$64K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,672 |
1,766 |
$63K |
| 82550 |
|
11,982 |
8,542 |
$62K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,531 |
3,183 |
$59K |
| 80076 |
|
8,620 |
7,357 |
$58K |
| 97161 |
|
902 |
743 |
$58K |
| 81001 |
|
19,665 |
15,955 |
$56K |
| 84703 |
|
7,369 |
6,156 |
$55K |
| 70486 |
|
512 |
454 |
$51K |
| 83690 |
|
8,628 |
7,213 |
$50K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
254 |
206 |
$46K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
451 |
251 |
$43K |
| 86901 |
|
1,784 |
1,531 |
$42K |
| 71250 |
|
552 |
477 |
$40K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,939 |
2,360 |
$39K |
| 80320 |
|
2,818 |
2,342 |
$38K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,401 |
3,449 |
$36K |
| 73630 |
|
1,630 |
1,392 |
$30K |
| 80061 |
Lipid panel |
2,512 |
2,239 |
$29K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
869 |
641 |
$28K |
| 85027 |
|
6,475 |
5,151 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
717 |
635 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
715 |
636 |
$27K |
| 72141 |
|
113 |
98 |
$27K |
| 80329 |
|
3,543 |
1,873 |
$26K |
| 87040 |
|
2,163 |
1,923 |
$25K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
63 |
52 |
$25K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,211 |
3,674 |
$24K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,271 |
4,724 |
$24K |
| 82948 |
|
6,108 |
4,173 |
$21K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
471 |
385 |
$21K |
| 82728 |
|
2,378 |
2,125 |
$20K |
| 97001 |
|
602 |
469 |
$20K |
| 73130 |
|
1,207 |
1,024 |
$20K |
| 73610 |
|
1,526 |
1,293 |
$20K |
| 73562 |
|
887 |
739 |
$20K |
| 85730 |
|
4,742 |
4,206 |
$19K |
| 72110 |
|
619 |
552 |
$17K |
| 73030 |
|
1,100 |
940 |
$16K |
| 82607 |
|
1,758 |
1,570 |
$16K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
239 |
185 |
$15K |
| 83735 |
|
2,597 |
1,899 |
$15K |
| 73110 |
|
981 |
839 |
$15K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
43 |
42 |
$14K |
| 85610 |
|
5,575 |
4,838 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
818 |
715 |
$14K |
| 96376 |
|
1,240 |
893 |
$14K |
| 76830 |
Ultrasound, transvaginal |
273 |
218 |
$12K |
| 84145 |
|
986 |
888 |
$12K |
| 82553 |
|
1,309 |
1,183 |
$12K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
563 |
425 |
$11K |
| 87430 |
|
1,540 |
1,406 |
$11K |
| 85378 |
|
1,867 |
1,727 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,362 |
1,203 |
$11K |
| 83605 |
|
1,348 |
1,143 |
$11K |
| 82746 |
|
1,265 |
1,123 |
$11K |
| 82805 |
|
474 |
395 |
$11K |
| 83550 |
|
1,987 |
1,778 |
$10K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,871 |
2,159 |
$9K |
| 84702 |
|
920 |
740 |
$9K |
| 97162 |
|
99 |
84 |
$8K |
| 73502 |
|
501 |
422 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
340 |
280 |
$8K |
| 90715 |
|
525 |
468 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
273 |
225 |
$8K |
| 83540 |
|
1,998 |
1,786 |
$8K |
| 96367 |
|
287 |
174 |
$7K |
| 82565 |
|
1,116 |
907 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,983 |
4,893 |
$7K |
| 86900 |
|
1,785 |
1,532 |
$7K |
| 81003 |
|
4,156 |
3,641 |
$7K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
207 |
172 |
$7K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
91 |
67 |
$6K |
| 93971 |
|
180 |
156 |
$6K |
| 87088 |
|
1,242 |
1,097 |
$6K |
| 87186 |
|
1,467 |
1,320 |
$5K |
| 74022 |
|
284 |
264 |
$5K |
| 87420 |
|
779 |
722 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,931 |
2,477 |
$5K |
| 86140 |
|
1,066 |
926 |
$5K |
| 87400 |
|
1,065 |
991 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,021 |
1,282 |
$5K |
| 87428 |
|
405 |
312 |
$4K |
| 85379 |
|
482 |
376 |
$4K |
| 73560 |
|
280 |
246 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
465 |
366 |
$4K |
| 94060 |
|
154 |
131 |
$4K |
| 84100 |
|
789 |
585 |
$4K |
| 72100 |
|
218 |
170 |
$4K |
| 82150 |
|
601 |
532 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,616 |
4,952 |
$3K |
| 85651 |
|
1,159 |
1,016 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
513 |
385 |
$3K |
| 83615 |
|
563 |
465 |
$3K |
| 84439 |
|
368 |
320 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,315 |
3,763 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,327 |
1,162 |
$2K |
| 99499 |
|
175 |
138 |
$2K |
| 87210 |
|
540 |
485 |
$2K |
| 74018 |
|
225 |
203 |
$2K |
| 95811 |
|
27 |
16 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$2K |
| J3490 |
Unclassified drugs |
1,823 |
1,175 |
$2K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
14 |
13 |
$2K |
| 87081 |
|
302 |
226 |
$2K |
| 74178 |
|
28 |
27 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
285 |
238 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,596 |
1,774 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,142 |
546 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
4,188 |
3,687 |
$2K |
| 72131 |
|
19 |
15 |
$2K |
| 86885 |
|
322 |
288 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
973 |
776 |
$2K |
| 12002 |
|
15 |
14 |
$2K |
| 87070 |
|
256 |
222 |
$2K |
| 76801 |
|
39 |
37 |
$1K |
| 87276 |
|
188 |
182 |
$1K |
| 73090 |
|
90 |
81 |
$1K |
| 76536 |
|
32 |
26 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,400 |
1,012 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
69 |
67 |
$1K |
| 76775 |
|
59 |
45 |
$1K |
| 93041 |
|
124 |
76 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
389 |
294 |
$1K |
| 97032 |
|
541 |
209 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
543 |
469 |
$965.46 |
| 93880 |
|
39 |
39 |
$935.75 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
111 |
67 |
$928.87 |
| 81025 |
|
180 |
134 |
$922.55 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,577 |
1,283 |
$911.80 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
18 |
15 |
$877.50 |
| 84520 |
|
392 |
300 |
$821.37 |
| 72072 |
|
28 |
28 |
$821.05 |
| 84436 |
|
51 |
36 |
$809.31 |
| 73590 |
|
63 |
41 |
$778.50 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
131 |
114 |
$706.29 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
25 |
25 |
$664.48 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
20 |
12 |
$597.30 |
| G0378 |
Hospital observation service, per hour |
2,248 |
1,989 |
$586.11 |
| 86850 |
|
241 |
186 |
$576.84 |
| 72170 |
|
54 |
52 |
$574.64 |
| 82009 |
|
147 |
130 |
$560.86 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
12 |
$560.00 |
| 82270 |
|
251 |
222 |
$528.81 |
| 73070 |
|
31 |
31 |
$501.40 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
144 |
117 |
$492.99 |
| 86304 |
|
34 |
24 |
$488.95 |
| J1630 |
Injection, haloperidol, up to 5 mg |
258 |
178 |
$473.08 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,310 |
762 |
$420.26 |
| 94726 |
|
29 |
26 |
$365.70 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,655 |
1,260 |
$354.75 |
| 82010 |
|
48 |
38 |
$316.56 |
| 82378 |
|
45 |
39 |
$316.21 |
| 97010 |
|
790 |
304 |
$313.47 |
| 94729 |
|
16 |
15 |
$302.21 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
29 |
25 |
$292.64 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
834 |
730 |
$259.63 |
| 84155 |
|
14 |
12 |
$257.06 |
| 87503 |
|
16 |
16 |
$233.76 |
| 93922 |
|
17 |
14 |
$182.58 |
| 36600 |
|
151 |
136 |
$119.00 |
| 87077 |
|
31 |
26 |
$115.30 |
| 86677 |
|
15 |
12 |
$103.60 |
| 83010 |
|
12 |
12 |
$96.71 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,372 |
1,104 |
$92.80 |
| 85045 |
|
59 |
55 |
$85.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
65 |
51 |
$51.54 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
63 |
51 |
$44.67 |
| C1769 |
Guide wire |
15 |
13 |
$37.96 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
12 |
12 |
$32.80 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
62 |
32 |
$27.10 |
| J1940 |
Injection, furosemide, up to 20 mg |
40 |
28 |
$14.68 |
| A9270 |
Non-covered item or service |
4,609 |
867 |
$12.54 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
34 |
30 |
$5.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
245 |
182 |
$0.12 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
257 |
203 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
49 |
38 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
15 |
14 |
$0.00 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
42 |
25 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
106 |
98 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
43 |
40 |
$0.00 |
| 99152 |
|
54 |
48 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
26 |
14 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
14 |
14 |
$0.00 |